Treating a wide range of patients with a unique ZEISS Optic. ZEISS CT LUCIA 621P/PY

Share this page

The new CT LUCIA from ZEISS is designed to compensate for a wide range of aberrations due to different corneal shapes and lens positions.

It presents three convincing benefits:

  • Consistant visual outcomes1
  • Excellent stability
  • Intuitive injector handling

Discover intuitive injector handling

How to implant the CT LUCIA 621P/PY

Just two steps for easy and intuitive injector preparation.

Ease of use

Watch the handling instructions animation

ZEISS OVDs

Benefit from ZEISS state-of-the-art OVD portfolio that supports you at each step of your monofocal cataract procedure.

Already sure what you want?

Get in contact with our Sales Team!

Listen to your fellow surgeons

CT LUCIA 621P – 1st time experiences

Antonino Cuttitta, MD, Italy
Otmar Ringhofer, MD, Germany
Hossein Shams, MD, Sweden
Andreas Borkenstein, MD, Austria
Igor di Carlo, MD, Italy
Antonino Cuttitta, MD Italy

The lens was very stable in the bag from the first week after surgery

Dr. Antonino Cuttitta, Examining the stability of a new aspheric IOL in cataract patients, Ophthalmology Times Europe Journal, Ophthalmology Times Europe March 2021, Volume 17, Issue 2

Latest ZEISS CT LUCIA study spotlights

These newly developed knowledge nuggets provide a quick and easy way to reveal the essence of recently published studies, carried out to review performance and handling of the ZEISS CT LUCIA. Created to visualize and present different content aspects in an engaging and concise way.

Antonino Cuttitta

Julius Hienert, Nino Hirnschall, Manuel Ruiss, Marlie Ullrich, Hannah Zwickl, Oliver Findl

Please note: ZEISS CT LUCIA 621P and ZEISS CT LUCIA 611P share the same lens design.

Your drylab experience

with ZEISS CT LUCIA 621PY & ZEISS miLOOP

This newly available experience kit has been developed to provide a unique way to discover two products at the same time: ZEISS miLOOP and ZEISS CT LUCIA 621PY.

After registration your local ZEISS representative will be in touch to arrange a convenient date to demo the kit either digital or in person.

Please note: The ZEISS CT LUCIA & ZEISS miLOOP drylab kit demo session is only available in the following countries: Austria, Denmark, Finland, France, Italy, Norway, Portugal, South Africa, Spain, Sweden.

CT LUCIA® 621P/PY is the recently enhanced monofocal, hydrophobic, C-Loop IOL from ZEISS, which allows you to treat a wide range of patients with a unique ZEISS Optic, featuring:

  • Consistent visual outcomes1
  • Excellent stability
  • Intuitive injector handling

The miLOOP® from ZEISS is a game-changing microinterventional lens fragmentation device, which is designed to remove the challenges of hard cataracts.

  • Reduced phaco energy and fluid use2
  • Minimal stress to capsule and zonules2
  • Reduced procedure and post-op treatment time2,3

Are you a patient?

Please visit our patient website for more information on cataract treatment:

Patient Material Download Center

Discover ZEISS educational and promotional patient tools for each step of the patient journey.

Get access to studies, peer reviews, explanation animations, testimonial videos and more!

Register now to this newsletter and receive a three-part e-mail series that provides you with deeper insights about the new CT LUCIA from ZEISS.

Unable to load form.

Learn what’s new

Interactive, animated insights

Watch the product video

Extract from surgeons experience article
Dr. med. Rüdiger Schmid FEBO Senior Consultant accuratis. Practice for Refractive Eye Surgery, Ulm & Eye competency centre Dillingen (Donau)

The features of the CT LUCIA 621P IOL, including its intraoperative handling characteristics, excellent refractive predictability, stability in the capsular bag, and consistently good visual outcomes, make it a good option to use as our standard IOL for cataract surgery patients with a monofocal lens.

Efficiency without compromise

ZEISS Cataract Workflow

Our industry leading portfolio connects the cataract workflow – from office to OR and back. Learn how you can achieve efficiency without compromise for your full cataract procedure with ZEISS.

 
  • 1 The data is taken from a simulation. The transferability of the results of such a simulation to patients with an actual implanted intraocular lenses has not yet been scientifically proven. Whether the simulated impressions correspond to the actual visual impressions must be clarified in future invasive studies.
  • 2 Ianchulev T, Chang DF, Koo E, et al Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study. British Journal of Ophthalmology April 2018.
  • 3 The majority of trained ZEISS miLOOP surgeons report a perceived reduction in overall procedure time (internal user survey, n=279, Iantech Data Analytics 20190708 PPT, data on file). Furthermore, ZEISS miLOOP usually results less trauma to capsular bag and zonules (see source 2) thereby potentially reducing the need for additional post-operative treatment (see source 4). Additionally, ZEISS miLOOP may reduce the likelihood of needing time-consuming post-operative treatments: One of major causes for endothelial cell loss in cataracts with increased density is the amount of phaco energy emitted into the eye during surgery (see sources 5,6,7,8,9). Thus, the ability to significantly reduce the overall phaco power by using ZEISS miLOOP (see source 2) may decrease the number of related complications that need post-operative treatments.
  • 4 Wont T et al, Phacoemulsification time and power requirements in phaco chop and divide and conquer nucleofractis techniques – J Cataract Refract Surg 2000; 26:1374-1378
  • 5 Soliman M et al, Relationship between endothelial cell loss and micro coaxial phacoemulsification parameters in noncomplicated cataract surgery – Clinical Ophthalmology 2012:6 503-510
  • 6 Pirazzoli G. et al, Effects of phacoemulsification time on the corneal endothelium using phacofracture and phaco chop techniques – J Cataract Refract Surg Vol 22, Sept 1996
  • 7 O’Brien Paul D. et al, Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident – J Cataract Refract Surg 2004; 30:839-843
  • 8 Hwang H B et al, Endothelial Cell Loss after Phacoemulsification according to Different Anterior Chamber Depths – Journal of Ophthalmology Vol 2015, Article ID 210716
  • 9 Park J et al, Comparison of phaco-chop, divide-and-conquer, and stop-and-chop phaco techniques in microincision coaxial cataract surgery – J Cataract Refract Surg 2013; 39:1463-1469